Literature DB >> 16530521

Kupffer cells abrogate cholestatic liver injury in mice.

Stephan Gehring1, Elizabeth M Dickson, Maryann E San Martin, Nico van Rooijen, Elaine F Papa, Mark W Harty, Thomas F Tracy, Stephen H Gregory.   

Abstract

BACKGROUND & AIMS: Biliary obstruction and cholestasis can cause hepatocellular apoptosis and necrosis. Ligation of the common bile duct in mice provides an excellent model in which to study the underlying mechanisms. Kupffer cells play a key role in modulating the inflammatory response observed in most animal models of liver injury. This study was performed to determine the role of Kupffer cells in the injury attending cholestasis.
METHODS: Mice were not treated or were rendered Kupffer cell-depleted by intravenous inoculation of multilamellar liposome-encapsulated dichloromethylene diphosphonate, the common bile duct was ligated and divided; sham-operated animals served as controls. Similarly, interleukin-6 (IL-6)-deficient and tumor necrosis factor-receptor-deficient mice underwent bile duct ligation (BDL) or sham operations.
RESULTS: Serum alanine transaminase levels were increased in all BDL mice at 3 days after surgery, but were significantly higher in IL-6-deficient mice or mice rendered Kupffer cell-depleted before ligation. Histologic examination of BDL livers showed portal inflammation, neutrophil infiltration, bile duct proliferation, and hepatocellular necrosis. Photoimage analyses confirmed more necrosis in the livers of Kupffer cell-depleted and IL-6-deficient animals. Purified Kupffer cells derived from BDL animals produced more IL-6 in culture. Similarly, Kupffer cells obtained by laser capture microdissection from the livers of BDL mice expressed increased levels of IL-6 messenger RNA. Recombinant mouse IL-6 administered 1 hour before BDL completely reversed the increased liver damage assessed otherwise in Kupffer cell-depleted mice.
CONCLUSIONS: These findings indicate that Kupffer cells abrogate cholestatic liver injury by cytokine-dependent mechanisms that include the production of IL-6.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530521     DOI: 10.1053/j.gastro.2005.11.015

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  39 in total

1.  Cholescintigraphic measurement of liver function: how is it different from other methods?

Authors:  Gerbail T Krishnamurthy; Shakuntala Krishnamurthy
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10       Impact factor: 9.236

2.  Alteration of canalicular transporters in a mouse model of total parenteral nutrition.

Authors:  Yuko Tazuke; Daniel H Teitelbaum
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

Review 3.  Living in the liver: hepatic infections.

Authors:  Ulrike Protzer; Mala K Maini; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

Review 4.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

5.  IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.

Authors:  Kate M O'Brien; Katryn M Allen; Cheryl E Rockwell; Keara Towery; James P Luyendyk; Bryan L Copple
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

6.  Extracellular factors and immunosuppressive drugs influencing insulin secretion of murine islets.

Authors:  V J Auer; E Janas; V Ninichuk; E Eppler; T S Weiss; S Kirchner; A M Otto; M J Stangl
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

7.  Contrasting responses of Kupffer cells and inflammatory mononuclear phagocytes to biliary obstruction in a mouse model of cholestatic liver injury.

Authors:  Caroline C Duwaerts; Stephan Gehring; Chao-Wen Cheng; Nico van Rooijen; Stephen H Gregory
Journal:  Liver Int       Date:  2012-12-13       Impact factor: 5.828

8.  Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage.

Authors:  Philip Wintermeyer; Chao-Wen Cheng; Stephan Gehring; Beth L Hoffman; Martin Holub; Laurent Brossay; Stephen H Gregory
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

Review 9.  Pathogenesis of Kupffer Cells in Cholestatic Liver Injury.

Authors:  Keisaku Sato; Chad Hall; Shannon Glaser; Heather Francis; Fanyin Meng; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2016-07-22       Impact factor: 4.307

10.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.